TYMSOS
TYMS opposite strand protein
Also known as: TYMOS_HUMAN
Protein identityUniProt · HPA
OverviewNCBI Gene
No narrative summary is available for TYMSOS in this catalog release; identity and structured annotations are shown without generated factual claims.
Canonical amino-acid sequenceUniProt
123 residues, UniProt reviewed canonical sequence.
>Q8TAI1|TYMSOS
1 MTPASGATAS LGRLRARPRS RWDAAYLPAV AAVCVARASH VPNGTLRFGV CKARRTMRPL
61 PRRIEVRTKR GPQRPAAPER SPQPRLPPSR HPSRRGPRRH LSGCSAPACR IPTGCRCPCG
121 RPSLocalizationUniProt · AlphaFold · HPA
Whether an antibody against TYMSOS can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Unknown
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.72
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads TYMSOS as an antibody target. Whether an autoantibody or antibody against TYMSOS could matter depends on whether native TYMSOS is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
TYMSOS is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label TYMSOS as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...